We also demonstrated that endocytosis of FcαR was dynamin-dependent by overexpressing a dominant-negative mutant of dynamin. The potential endocytic motif for FcαR was also examined. Unexpectedly, we found that the entire cytoplasmic domain of FcαR was not required for the endocytic process of FcαR. We conclude that endocytosis of FcαR is clathrin-and dynamin-dependent, but is not regulated by Rab5, and the endocytic motif is not located in the cytoplasmic domain of FcαR.
Introduction
In humans, IgA is the most abundant antibody in mucosal surfaces and the second most abundant antibody in blood [1, 2] . IgA plays important roles in both mucosal and systemic immunity [3, 4] . FcαR (CD89), the Fc receptor for IgA, plays crucial roles in IgA-mediated immune responses by coupling the innate and adaptive immune responses in effector cell activation. Binding of antigen-complexed IgA to FcαR initiates a variety of responses, and endocytosis is one of them [5, 6] .
It has been known for a long time that IgA and IgAcomplexed immune complex can be internalized by FcαR [7] . However, the underlying mechanism remains unknown. Since FcαR is devoid of recognized signaling
Results

Endocytosis of FcαR in U937 cells
The U937 cell is a human cell line with monocytic characteristics and naturally expresses FcαR. Previous study shows that FcαR undergoes rapid endocytosis in U937 cells [12] . Therefore, U937 cells were used to investigate the endocytic pathway(s) of FcαR. Several chemical inhibitors were used to selectively block clathrin-or caveolae/lipid raft-mediated endocytosis, which are two endocytic pathways commonly used by many membrane receptors. As shown in Figures 1A and 1B , blocking clathrin-mediated endocytosis by hypertonic sucrose (0.4 M), MDC (100 µM) and K + depletion [34] [35] [36] dramatically inhibited FcαR internalization. In comparison, FcαR endocytosis was hardly inhibited when cells were treated with Filipin III (5 µg/ml) or nystatin (50 µg/ ml), which is able to inhibit caveolae/lipid raft-mediated endocytosis [37] [38] [39] .
Clathrin-dependent pathway does not but some clathrin-independent pathways require tyrosine kinase activity for ligand internalization [40] [41] [42] . So, we examined whether tyrosine kinase activity was required for FcαR endocytosis by using tyrosine kinase inhibitors, genistein and herbimycin A. As shown in Figures 1A and 1B, treatment of cells by genistein (100 µg/ml) or herbimycin A (1 µM) had no influence on FcαR endocytosis, suggesting that tyrosine kinase activity was not required for FcαR endocytosis and further indicating that the endocytosis was mediated by a clathrin-dependent pathway.
Endocytosis of FcαR in transfected CHO cells
To study mechanisms of FcαR endocytosis, a stable transfectant of FcαR in CHO cells was established. Flow cytometry analysis showed that transfected CHO cells expressed FcαR on cell surface ( Figure 2A ) and were able to bind IgA ( Figure 2B ). The molecular mass of expressed FcαR was between 55 and 75 kDa ( Figure 2C ), which was similar to the naturally expressed receptor.
To investigate whether the endocytic pathway of FcαR in CHO cells is the same as that in U937 cells, which naturally express FcαR, we performed chemical inhibitor assays in CHO cells stably expressing FcαR. As shown in Figures 2D and 2E , both confocal microscopy and flow cytometry analysis showed that hypertonic sucrose (0.4 M), MDC (100 µM) and K + depletion dramatically inhibited FcαR endocytosis, whereas Filipin III (5µg/ml) or nystatin (50 µg/ml) was unable to do so. Tyrosine kinase inhibitors, genistein (100 µg/ml) and herbimycin A (1 µM), were also unable to inhibit FcαR endocytosis in CHO cells. As a control, CHO cells that were not transfected with FcαR did not bind or internalize IgA or FITC-conjugated MIP8a, demonstrating that endocytosis of IgA or FITC-conjugated MIP8a in transfected CHO cells was mediated by FcαR, but not other unidentified receptors (data not shown). Taken together, these results suggested that endocytosis of FcαR in CHO cells followed the same pathway as that in U937 cells.
Dominant-negative mutants of Eps15 inhibit FcαR internalization
Eps15 is a protein that binds directly to the plasma membrane adaptor AP-2 and is required for clathrinmediated endocytosis. Overexpression of dominantnegative mutants of Eps15 can selectively block clathrinmediated endocytosis [43] . So, we overexpressed dominant-negative mutants of Eps15 to further examine whether FcαR was internalized via clathrin-mediated endocytosis. EGFP-tagged Eps15-D3∆2 (wild-type (WT) control, which has no influence on clathrin-mediated endocytosis) and two EGFP-tagged dominant-negative mutants, Eps15-DIII and Eps15-EH29, were transiently transfected into CHO cells stably expressing FcαR. The inhibitory effect of Eps15 mutants on clathrin-mediated endocytosis was examined by uptake of Texas Redconjugated transferrin (Texas Red-Tfn). As shown in Figures 3A and 3B , uptake of Texas Red-Tfn was inhibited by up to 40%-60% when cells were transfected with EGFP-tagged Eps15-EH29 and Eps15-DIII. The WT control EGFP-tagged Eps15-D3∆2 had no effect on Tfn uptake. Similar results were observed for FcαR endocy- , MDC (100 µM), Filipin III (5 µg/ml), nystatin (50 µg/ml), genistein (100 µg/ml) or herbimycin A (1 µM) for 60 min at 37 °C, or subjected to K + depletion as described in Materials and Methods. Cells were then incubated with FITC-labeled MIP8a-F(ab′) 2 in medium containing inhibitors for another 60 min at 4 °C, washed and transferred quickly to pre-warmed (37 °C) medium containing inhibitors and incubated for 30 min to allow endocytosis. Then, cells were fixed and nuclei were stained by Hoechst 33258 (blue). Endocytosis was examined by confocal laser-scanning microscope. Bar represents 7. tosis. Both Eps15-EH29 and Eps15-DIII but not Eps15-D3∆2 inhibited internalization of FcαR ( Figures 3C and  3D ), indicating that FcαR was internalized via clathrinmediated endocytosis.
FcαR endocytosis is abolished when clathrin heavy chain is depleted by short-hairpin (shRNA)
The above mentioned inhibition experiments using chemical inhibitors and dominant-negative mutants of Eps15 indicated that endocytosis of FcαR was dependent on clathrin. To obtain direct evidence, RNA interference was used to knockdown clathrin heavy chain (CHC). We first tried to knockdown CHC in CHO cells, but failed (data not shown). Considering that our target sequence (GTA ATC CAA TTC GAA GAC C) against CHC is only conserved in humans and mice, but not in 
Endocytosed FcαR is localized in Rab5-and Rab11-positive endosomes, but endocytosis of FcαR is not regulated by Rab5
Small GTPases broadly regulate endocytosis, intracellular trafficking and membrane fusion of endocytic vesicles. Rab5, Rab11, Rab7 and Rab9 are recognized as Figure S1A ). This colocalization reached a maximum at 30 min and then decreased slowly. Colocalization of FcαR with Rab11 was observed at 10 min and reached a maximum at 60 min, then decreased through the following 3 h (Supplementary information, Figure  S1B ). In comparison, little colocalization between FcαR and Rab7 or Rab9 was observed through the whole time course (Supplementary information, Figure S2 ). These data suggest that internalized FcαR went into Rab5-positive early endosomes, then were possibly recycled back to the cell surface through Rab11-positive recycling endosomes, but not delivered to late endosomes. Rab5-S34N is a dominant-negative mutant of Rab5, which has been shown to be able to inhibit endocytosis of some receptors [33] . Since FcαR was colocalized with Rab5, we next examined whether the endocytosis of FcαR was regulated by Rab5. At 48 h posttransfection of EGFP-tagged Rab5-S34N in CHO cells stably ex- pressing FcαR, cells were allowed to internalize TRITCconjugated MIP8a-F(ab′) 2 for 30 min at 37 °C. As shown in Figure 6B , overexpression of dominant-negative mutant of Rab5 did not block the internalization of FcαR in CHO cells, suggesting that the endocytosis of FcαR was not regulated by Rab5.
FcαR endocytosis is dynamin dependent
Clathrin-dependent and a subset of clathrin-independent endocytosis require the activity of dynamin, a GTPase responsible for pinching vesicles from the plasma membrane and thereby driving cargo internalization into carrier vesicles [17] [18] [19] . To determine if FcαR internalization was dynamin dependent, HA-tagged WT dynamin (Dyn-WT-HA) or a dominant-negative dynamin mutant K44A (Dyn-K44A-HA) was transiently transfected into CHO cells stably expressing FcαR. Similar to Tfn ( Figures 7A and 7B) , FcαR endocytosis was dramatically reduced in cells expressing dominant-negative dynamin mutant, but not in cells expressing the WT dynamin (Figures 7C and 7D ), suggesting that dynamin was required for FcαR endocytosis.
The endocytic motif of FcαR is not located in the cytoplasmic domain of FcαR
Sorting of transmembrane proteins to endosomes is mediated by consensus motifs present within the cytoplasmic domains of these proteins, the most common endocytic motifs are tyrosine-based motif YXXØ (X stands for any amino acid and Ø stands for an amino acid residue with a bulky hydrophobic side chain) and dileucinebased signals [DE]XXXL[LI] or DXXLL [44] . As no such conserved motifs are found within the cytoplasmic domain of FcαR, we speculate that some unrecognized motif within the cytoplasmic domain might be responsible for FcαR endocytosis. To test this hypothesis, the entire cytoplasmic domain of FcαR (41 amino acids) was deleted. This tail-less FcαR was transiently transfected Endocytosis results showed that, just like the full-length receptor, the tail-less FcαR was able to be internalized both in COS-7 ( Figure 8A ) and CHO cells ( Figure 8B ). To test whether this tail-less FcαR is internalized through the same pathway as the full-length receptor, chemical inhibitors of clathrin-or caveolae/lipid raftmediated endocytosis pathway were used. As shown in Figures 8C and 8E , hypertonic sucrose (0.4 M) and MDC (100 µM), but not Filipin III (5 µg/ml), inhibited endocytosis of tail-less FcαR, suggesting that this tail-less FcαR was also endocytosed through a clathrin-dependent pathway. Next, tail-less FcαR was cotransfected with pSUPER or pSUPER-shRNA CHC in Hela cells, as done for full-length FcαR. As expected, CHC was depleted in pSUPER-shRNA CHC-transfected cells, but not in pSUPER-transfected cells. In addition, endocytosis of tail-less FcαR in CHC knockdown Hela cells was also inhibited (Figures 8D and 8F ). These data demonstrated that endocytosis of tail-less FcαR was, like full-length FcαR, also through the clathrin-dependent pathway.
We also compared the kinetics of endocytosis of FcαR and tail-less FcαR in stably transfected CHO cells, and the result showed no difference between them ( Figure  8E ). These data suggest that endocytosis of both full- 
Discussion
Although endocytosis is a well-known feature of FcαR, the mechanism remains unknown. Previous studies showed that FcαR redistributed into lipid raft 30 s after being cross-linked, but this redistribution decreased to a basal level within 5 min before endocytosis occurred [9, 10] . In addition, FcαR was not colocolized with the lipid raft marker, GM-1 [10] . These results suggested that endocytosis of FcαR was not lipid raft mediated. In the present study, we investigated the FcαR endocytic pathway and demonstrated that FcαR was internalized through a clathrin-and dynamin-dependent pathway.
Endocytosis of FcαR was blocked by hypertonic sucrose, MDC and K + depletion, but not by nystatin and Filipin III, suggesting that FcαR underwent endocytosis via a clathrin-dependent pathway, but not the caveolae or lipid raft-mediated endocytosis. Furthermore, tyrosine kinases were not required for FcαR endocytosis, as genistein and herbimycin A did not inhibit the endocytosis of FcαR. This is very similar to FcγRI (CD64), which can undergo endocytosis in the absence of γ-chain in a tyrosine kinase-independent manner [45] . In comparison, tyrosine kinase is required for the endocytosis of FcγRIIA [46] . These data suggest that endocytosis of different Fc receptors is differentially regulated by tyrosine kinase.
To validate the results of chemical inhibitor experiments, dominant-negative mutants of Eps15 were used, which can specifically inhibit clathrin-mediated endocytosis [43] . As shown in Figure 3 , expression of both mutants, but not WT control Eps15, blocked the endocytosis of FcαR. This further demonstrated that FcαR was internalized through clathrin-mediated endocytosis. Moreover, FcαR endocytosis was abolished when clathrin heavy chain was depleted by shRNA, providing direct evidence that clathrin was required for endocytosis of FcαR. Taken together, these data demonstrate that endocytosis of FcαR is clathrin-mediated.
FcαR is expressed on various myeloid cells either as monomers or FcR-γ-chain-associated multimers [12] . Previous studies using IIA1.6 and RBL-2H3 cells showed that FcR γ-chain was not required for FcαR-mediated endocytosis of IgA and IgA immune complexes [9, 12] . Here, we demonstrated that FcαR was able to undergo endocytosis in transfected CHO, COS-7 and Hela cells, which are not myeloid cells and devoid of γ-chain. Therefore, endocytosis is an intrinsic characteristic of FcαR itself in various kinds of cells, regardless of the presence of FcR γ-chain.
Although FcR γ-chain is not required for FcαR endocytosis, it may affect the fate of FcαR after it enters the cell. Previous study showed that, in transfected RBL cells, internalized FcαR-R209L (a mutant FcαR where arginine 209 at the transmembrane region is replaced by lysine, therefore it cannot associate with the γ-chain) was colocalized with Tfn [12] , a known marker for the endocytosis-recycling route. In agreement with these results, we found that internalized FcαR went into Rab5-and Rab11-positive early endosomes and recycling endosomes, and it hardly went to Rab7-and Rab9-positive late endosomes. In contrast, when FcαR was associated with γ-chain, the endocytosed ligand was sorted to lysosomes for degradation and further for antigen presentation [13] . Therefore, γ-chain plays important roles in determining the intracellular trafficking routes of FcαR after endocytosis [12, 13] .
Although Rab5 has been shown to be able to regulate the endocytosis of some membrane receptors [33] , overexpression of a dominant-negative mutant of Rab5 (Rab5-S34N) had no influence on the endocytosis of FcαR in this study. This indicates that endocytosis of FcαR is not regulated by Rab5, similar phenomenon have been reported for other receptors [47, 48] . It is believed that signals for clathrin-mediated endocytosis lie in the cytoplasmic domain of membrane receptors. Because there are no such conserved endocytic motifs within the cytoplasmic domain of FcαR, we, as well as others [13] , speculated that there might be some unrecognized motif within the cytoplasmic domain of FcαR, which could interact with endocytic machinery and mediate endocytosis of FcαR. However, we surprisingly found that FcαR could still be internalized when the entire cytoplasmic domain was deleted. What is more interesting is that endocytosis of this tail-less FcαR was inhibited by hypertonic sucrose, MDC and knockdown of CHC, demonstrating that endocytosis of tail-less FcαR was also clathrin dependent. Nevertheless, this finding is consistent with the fact that no conserved endocytic motifs are found within the cytoplasmic domain of FcαR. A few studies showed that signals for endocytosis could localize in the extracellular and/or transmembrane domain of a receptor [45, 49, 50] . For example, it has been reported that endocytic motif of another Fc receptor, FcγRI (CD64), localizes within the extracellular domain of the receptor rather than the transmembrane or cytoplasmic domain [45] . How FcαR could be internalized through clathrin-mediated endocytosis in the absence of its cytoplasmic domain is not clear at present.
First, it is possible that the endocytic motif for FcαR might also be localized within the extracellular domain of FcαR, just like FcγRI. The extracellular region of FcαR contains two Ig-like domains, EC1 and EC2. EC1 contains the binding site for IgA, and our mAb against FcαR also recognizes EC1. Deletion of EC1 will result in a receptor without the capacity to bind its natural ligand and our mAb will not recognize it. FcαR without the entire EC2 domain is actually an isoform of FcαR, which is generated through alternative splicing [5] . This isoform of FcαR has been only detected at mRNA level, and no surface expression on natural cells has been reported [51] . So, EC2 is important for the surface expression of FcαR. Therefore, to characterize the exact endocytic motif of FcαR, one would need to make site-directed mutations within its extracellular or transmembrane domain.
Second, we think that characterizing endocytic adaptors of FcαR is more important, because wherever the endocytic motif is localized, this motif must interact with the endocytic adaptors to accomplish endocytosis. So, we have tried to identify FcαR-interacting endocytic adaptors (or other transmembrane molecules) by CoIP. However, silver staining generated many weak bands (data not shown), which were difficult to characterize and might reflect non-specific bindings. Other techniques, such as yeast two-hybrid screening, might be able to identify FcαR-interacting proteins.
In conclusion, we demonstrate that FcαR is able to be internalized through clathrin-mediated endocytosis in the absence of its cytoplasmic domain. Our data shed new light on the mechanism of clathrin-mediated endocytosis by showing that the endocytic motif does not have to be localized in the cytoplasmic domain of the receptor. Further studies are needed for characterizing the exact endocytic motif of FcαR and endocytic adaptors that help tailless FcαR accomplish endocytosis. Better understanding of the mechanisms of FcαR endocytosis will help us elucidate the role of this receptor in regulating serum IgA homeostasis and IgA-mediated immune responses.
Materials and Methods
Antibody and agents
The murine anti-FcαR mAb MIP8a, rabbit anti-FcαR polyclonal antibody, FITC or tetramethylrhodamine isothiocyanate (TRITC, USA)-labeled F(ab′) 2 fragments of MIP8a and human IgA2 were prepared as described previously [52] [53] [54] . Rabbit anticlathrin heavy chain (CHC) polyclonal antibody (ab21679) was from Abcam (Cambridge, UK), mouse anti-CHC mAb (TD-1) was from Santa Cruz Biotechnology (Santa Cruz, USA). Goat anti-HA polyclonal antibody, HRP-conjugated goat anti-mouse IgG polyclonal antibody and FITC-conjugated goat anti-rabbit IgG polyclonal antibody were from Zhongshan Biotechnology Co (Beijing, China). Sucrose, monodansylcadaverine crystalline (MDC), Filipin III, nystatin, genistein, herbimycin A and phorbol-12-myristate-13-acetate (PMA) were from Sigma-Aldrich (St. Louis, MO, USA). Texas Red-conjugated Tfn was from Invitrogen (Carlsbad, USA).
Plasmids
The cDNA of FcαR was cloned from human peripheral white blood cells by reverse transcription PCR, and inserted into the BamHI and XhoI sites of pcDNA 3.1 vector (Invitrogen). The tail-less FcαR (the entire cytoplasmic domain of FcαR was deleted) was constructed by standard PCR procedure and inserted into pcDNA3.1 vector at the same sites. EGFP-tagged Eps15-EH29, DIII and D3∆2 were provided by Dr Alexandre Benmerah [43] . HA-tagged WT dynamin and its dominant-negative mutant K44A were provided by Dr Sandra Schmid [19] . EGFP-tagged Rab7, Rab9 and Rab11 were gifts from Dr Richard E Pagano [55] . EGFP-tagged Rab5 and Rab5-S34N were provided by Dr Feng Du (Tsinghua University, China).
Cell culture and transfection
U937 cells were grown in RPMI1640 containing 10% fetal bovine serum, and CHO, COS-7 and Hela cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum and antibiotics, at 37 °C in a humidified atmosphere of 5% CO 2 . Cells were transfected with plasmids encoding of FcαR using Lipofectamine 2000 (Invitrogen). Stably transfected CHO cells were selected with 800 µg/ml G418 and were evaluated for receptor expression by flow cytometry and western blot. Cells stably expressing FcαR were transiently transfected with EGFPtagged WT and dominant-negative mutant of Eps15, HA-tagged dynamin WT and K44A or EGFP-tagged Rab GTPases using Li- 
Manipulation of endocytic pathways by chemical inhibitors
Because the expression level of FcαR on U937 cells is relatively low, the signal of FcαR staining under laser-scanning confocal microscopy is weak. So, PMA was used to increase the expression level of FcαR [12] . U937 cells that grew on poly-lysinecoated coverslip were treated with 10 −7 M PMA for 24 h before experiments. CHO cells stably expressing FcαR were cultured as described above. 24 h prior to experiments, cells were seeded onto coverslip placed in 24-well plates and cultured for another 24-48 h. On the day of experiment, cells were pretreated with 0.4 M sucrose, 100 µM MDC, 5 µg/ml Filipin III, 50 µg/ml nystatin, 100 µg/ml genistein or 1 µM herbimycin A for 1 h at 37 °C. K + depletion was done according to the procedure of Altankov and Grinnell [36] . Briefly, cells were rinsed once with potassium-free buffer (140 mM NaCl, 20 mM Hepes, 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mg/ ml D-glucose, pH 7.4), then incubated in hypotonic medium (50% potassium-free buffer/50% H 2 O) for 5 min at 37 °C, followed by incubation in potassium-free buffer for 20 min at 37 °C. Cells were then cooled to 4 °C and incubated with FITC or TRITClabeled MIP8a-F(ab′) 2 in medium or potassium-free buffer at 4 °C for 30 min. Cells were washed with cold HBSS (or potassium-free buffer), then transferred quickly into pre-warmed (37 °C) medium supplemented with inhibitors or potassium-free buffer, followed by incubation at 37 °C for various times to allow for endocytosis. Controls constituted of equal volume of respective solvent added in medium. In K + depletion assay, control was conducted with 10 mM KCl added in potassium-free buffer. At the end of endocytosis, cells were placed on ice, fixed with 4% paraformaldehyde and mounted. The inhibition of endocytosis was determined by confocal microscopy and quantified by flow cytometry.
Flow cytometry
To analyze the expression of FcαR on CHO cells, stably transfected cells were incubated with MIP8a or isotype control MOPC21 (Sigma-Aldrich) in 1% BSA/PBS followed by incubation with FITC-conjugated goat anti-mouse IgG. Then samples were analyzed by a flow cytometer (FACS Aria, USA). For IgA binding, CHO cells or FcαR stably transfected CHO cells were incubated with FITC-conjugated human IgA2 in 1% BSA/PBS for 60 min on ice, then washed and analyzed by flow cytometry.
Endocytosis of FcαR in U937 cells and stably transfected CHO cells was quantified by flow cytometry. Cells were incubated with MIP8a in medium (or medium containing inhibitors) for 60 min on ice, washed with cold HBSS thrice (for U937 cells, cells were centrifuged at 400 × g for 2 min after each wash), then cells were incubated in medium (or medium containing inhibitors) at 37 °C to allow for endocytosis for various times. 
Immunofluoresence and confocal microscopy
CHO cells stably expressing FcαR were allowed to grow on coverslip as described above. 24 h later, cells were transfected with EGFP-tagged Eps15-EH29, DIII, D3∆2, HA-tagged dynamin WT, dynamin K44A or EGFP-tagged Rab GTPases. In shRNA experiment, Hela cells were cotransfected with pcDNA3.1-FcαR and pSUPER-shRNA CHC at the ratio of 1:1. At 48 h posttransfection, cells were cooled to 4 °C and incubated with FITC or TRITClabeled MIP8a-F(ab′) 2 in medium at 4 °C for 60 min, then washed with cold HBSS and transferred quickly into pre-warmed (37 °C) medium, followed by incubation at 37 °C for various times. At the end of endocytosis, cells were placed on ice and fixed with 4% paraformaldehyde. To detect HA and clathrin, cells were permeabilized by 0.2% Triton X-100 for 10 min at room temperature, then blocked with 5% horse serum for 30 min. Cells were incubated with rabbit anti-clathrin heavy chain polyclonal antibody or goat anti-HA polyclonal antibody in 1% BSA/PBS for 60 min at room temperature, then washed with 1% BSA/PBS, followed by incubation with FITC-conjugated goat anti-rabbit IgG or rabbit antigoat IgG for another 60 min at room temperature. Then, cells were washed and nuclei were stained with Hoechst 33258 (Merck & Co, USA). The colocalization of endocytosed MIP8a-F(ab′) 2 and Rabs GTPases during various time points was determined by a confocal laser-scanning microscope system (Leica TCS SP2 SE, Germany) with 100×1.44 numerical aperture oil immersion lens. The effects of Eps15, dynamin and Rabs GTPases on FcαR endocytosis were also examined by confocal microscopy. Each image was a single confocal slice. For quantitative analysis, the fluorescence intensity of endocytosed TRITC-conjugated MIP8a-F(ab′) 2 within cells were quantified by Image J software (NIH, USA). In each experiment, 100 untransfected cells and 100 transfected cells were quantified for their endocytosis of TRITC-conjugated MIP8a-F(ab′) 2 , and the results were expressed as mean ± SEM.
Transferrin endocytosis assay
First, cells were serum starved by incubation in medium without serum for 1 h at 37 °C. Then, cells were incubated with 50 µg/ ml Texas Red-Tfn in medium without serum at 37 °C for various times. At the end of endocytosis, cells were cooled to 4 °C quickly and washed with cold HBSS. Then, cells were fixed, stained with Hoechst 33258, mounted and analyzed as described above.
RNA interference
Target sequence of shRNA duplexes against CHC (GTA ATC CAA TTC GAA GAC C) was obtained from a published study [56] . For the expression of shRNA, oligonucleotides containing target sequence to CHC were synthesized and duplex oligo DNA was inserted into the pSUPER vector (Oligoengine, USA). This plasmid DNA was cotransfected with pcDNA3.1-FcαR in Hela cells. At 72 h posttransfection, the efficiency of CHC depletion and its influence on FcαR endocytosis were examined by confocal microscopy. To knockdown CHC in U937 cells, a lentiviral shRNA vector pLVTHM [57] was used. pLVTHM expresses GFP and shRNA simultaneously, therefore infected cells can be easily detected by fluorescent microscopy and also can be sorted by FACS. The same target sequence of CHC was cloned in pLVTHM. pLVTHM or pLVTHM-shRNA CHC was cotransfected with packaging vector psPAX2 and envelope vector pMD2.G into 293T cells. Then U937 cells were infected with supernatants from packing cells supplemented with 8 µg/ml Polybrene. After 3 infections, cells with high GFP expression level were sorted by FACS. The expression of CHC in GFP-positive U937 cells was determined by western blot and fluorescent staining.
Western blot
To validate FcαR stably expressed in CHO cells, FcαR from 5×10 6 cells was purified with anti-FcαR mAb-coupled beads as described previously [50] , separated by 10% SDS-PAGE and transferred onto a nitrocellulose membrane. After blocking with 5% defatted milk for 1 h at room temperature, membranes were incubated with rabbit anti-FcαR polyclonal antibody (1: 500) overnight at 4 °C. Then, membranes were washed with PBS containing 0.05% Tween-20 and incubated with HRP-conjugated goat anti-rabbit IgG (1: 3 000) at room temperature for 1 h. Then membranes were visualized by SuperSignal West Pico chemiluminescent substrate (Pierce, USA). In RNA interference experiment, depletion of CHC was also examined by western blot. Briefly, 72 h posttransfection, equal number of pSUPER or pSUPER-shRNA CHC-transfected cells was lysed with loading buffer and separated by 5%-18% SDS-PAGE, then proteins were transferred onto a nitrocellulose membrane. Mouse monoclonal anti-CHC antibody (TD-1) was used to detect CHC (1: 200).
